Effect of Agastya( Sesbania grandiflora Linn.) Puspa and Patra on Shira shoola(Migrane)
Phase 1
- Conditions
- Health Condition 1: null- Patients complain with Sirahshoola
- Registration Number
- CTRI/2015/07/006009
- Lead Sponsor
- Institute for post gradute teaching and research in Ayurevda gujarat ayurveda university jamnagar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
Patients having age between 20-50 yrs
Irrespective of sex
patient having sign and symptoms of shirashoola (Ardhavbhedak-classical & other)
Exclusion Criteria
Patients having age less than 20 years and more than 50 years
Headache other then Migraine
Patients suffering Hypertension and any major systemic disease
Suryavarta, Anantavata, Shankhaka
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method relief in the SirahshoolaTimepoint: up to 15 days
- Secondary Outcome Measures
Name Time Method relief in the MigraineTimepoint: up to 15 days
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Sesbania grandiflora's efficacy in treating Shira shoola (migraine)?
How does Agastya Puspa and Patra compare to standard migraine therapies like triptans in clinical trials?
Are there specific biomarkers linked to response prediction in CTRI/2015/07/006009 Ayurvedic migraine study?
What adverse events are reported in Phase I trials of Ayurvedic interventions for chronic migraine?
What combination therapies with Sesbania grandiflora are being explored for neuroinflammatory headache disorders?